跳转至内容
Merck
CN
  • Physical characterization of drug:polymer dispersion behavior in polyethylene glycol 4000 solid dispersions using a suite of complementary analytical techniques.

Physical characterization of drug:polymer dispersion behavior in polyethylene glycol 4000 solid dispersions using a suite of complementary analytical techniques.

Journal of pharmaceutical sciences (2014-05-16)
Dipy M Vasa, Namita Dalal, Jeffrey M Katz, Rahul Roopwani, Akshata Nevrekar, Harshil Patel, Ira S Buckner, Peter L D Wildfong
摘要

Fifteen model drugs were quenched from 3:1 (w/w) mixtures with polyethylene glycol 4000 (PEG4000). The resulting solids were characterized using powder X-ray diffraction (PXRD), analysis of pair distribution function-transformed PXRD data (where appropriate), hot-stage polarized light microscopy, and differential scanning calorimetry (DSC). Drug/polymer dispersion behavior was classified using the data from each technique, independent of the others, and limitations to single-method characterization of PEG-based systems are highlighted. The data from all characterization techniques were collectively used to classify dispersion behavior, which was compared with single-technique characterization. Of the 15 combinations, only six resulted in solids whose dispersion behavior was consistently described using each standalone technique. The other nine were misclassified using at least one standalone technique, mainly because the phase behavior was ambiguously interpreted when only the data from one technique were considered. The data indicated that a suite of complementary techniques provided better classifications of the phase behavior. Of all the quenched solids, only cimetidine was fully dispersed in PEG4000, suggesting that it solidified from a completely miscible mixture of molten drug and polymer that did not phase separate upon cooling. In contrast, ibuprofen and PEG4000 completely recrystallized during preparation, whereas the remaining 13 drugs were partially dispersed in PEG4000 at this composition.

材料
货号
品牌
产品描述

Sigma-Aldrich
褪黑素, powder, ≥98% (TLC)
Sigma-Aldrich
吲哚美辛, 98.5-100.5% (in accordance with EP)
Sigma-Aldrich
伊曲康唑, ≥98% (HPLC)
Sigma-Aldrich
硝苯地平, ≥98% (HPLC), powder
Sigma-Aldrich
对氨基苯磺酰胺, ≥98%
USP
褪黑素, United States Pharmacopeia (USP) Reference Standard
Sigma-Aldrich
吲哚美辛, meets USP testing specifications
Sigma-Aldrich
西咪替丁
Sigma-Aldrich
特非那定
USP
对氨基苯磺酰胺, United States Pharmacopeia (USP) Reference Standard
USP
对氨基苯磺酰胺, United States Pharmacopeia (USP) Reference Standard
USP
硝苯地平, United States Pharmacopeia (USP) Reference Standard
USP
吲哚美辛, United States Pharmacopeia (USP) Reference Standard
USP
西咪替丁, United States Pharmacopeia (USP) Reference Standard
Supelco
甲苯磺丁脲, analytical standard
Sigma-Aldrich
对氨基苯磺酰胺, puriss. p.a., ≥98% (calc. to the dried substance)
Supelco
磺胺熔点标准品, Pharmaceutical Secondary Standard; Certified Reference Material
Supelco
吲哚美辛, Pharmaceutical Secondary Standard; Certified Reference Material
Supelco
对氨基苯磺酰胺, VETRANAL®, analytical standard
Supelco
硝苯地平, Pharmaceutical Secondary Standard; Certified Reference Material
Supelco
西咪替丁, Pharmaceutical Secondary Standard; Certified Reference Material
Supelco
氯磺丙脲, analytical standard, ≥97%
对氨基苯磺酰胺, European Pharmacopoeia (EP) Reference Standard
吲哚美辛, European Pharmacopoeia (EP) Reference Standard
伊曲康唑, European Pharmacopoeia (EP) Reference Standard
甲苯磺丁脲, European Pharmacopoeia (EP) Reference Standard
特非那定, European Pharmacopoeia (EP) Reference Standard
氯磺丙脲, European Pharmacopoeia (EP) Reference Standard
西咪替丁, European Pharmacopoeia (EP) Reference Standard
硝苯地平, European Pharmacopoeia (EP) Reference Standard